Articles published by GlobeNewswire
Mod Op Launches “Mod Op AI Risk Intelligence” to Audit Harmful AI-Generated Content
February 23, 2026
From Mod Op
Via GlobeNewswire
UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026
February 23, 2026
From UroGen Pharma Ltd.
Via GlobeNewswire
Tickers
URGN
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference
February 23, 2026
Via GlobeNewswire
Tickers
PLRX
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
February 23, 2026
From Aligos Therapeutics
Via GlobeNewswire
Tickers
ALGS
Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC
February 23, 2026
Via GlobeNewswire
Tickers
RXRX
NodThera to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 23, 2026
From NodThera
Via GlobeNewswire
ARRAY Technologies to Participate in Upcoming Conference for the Investor Community
February 23, 2026
Via GlobeNewswire
Tickers
ARRY
From VenHub Global Inc.
Via GlobeNewswire
Tickers
VHUB
From Cerevance, Inc.
Via GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
February 23, 2026
Via GlobeNewswire
Tickers
RXRX
BridgeBio to Participate in March Investor Conferences
February 23, 2026
Via GlobeNewswire
Tickers
BBIO
Crescent Biopharma to Present at March Investor Conferences
February 23, 2026
Via GlobeNewswire
Tickers
CBIO
Verisk Analytics, Inc. Enters into $1.5 Billion Accelerated Share Repurchase Transaction
February 23, 2026
Via GlobeNewswire
Tickers
VRSK
New, Patent-Pending Tubing Anchor Catcher Now Available from TechTAC
February 23, 2026
From TechTAC
Via GlobeNewswire
C4 Therapeutics to Participate in Upcoming March Conferences
February 23, 2026
Via GlobeNewswire
Tickers
CCCC
Cyber Acoustics Celebrates 30 Years of Audio Innovation
February 23, 2026
Via GlobeNewswire
uniQure to Announce 2025 Financial Results
February 23, 2026
From uniQure Inc.
Via GlobeNewswire
Tickers
QURE
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
February 23, 2026
Via GlobeNewswire
Tickers
GLUE
Pairwise Licenses Fulcrum® CRISPR Platform to Wild Bioscience
February 23, 2026
From Pairwise
Via GlobeNewswire
Plug To Announce 2025 Fourth Quarter and Year-End Results
February 23, 2026
From Plug Power, Inc.
Via GlobeNewswire
Tickers
PLUG
Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 23, 2026
Via GlobeNewswire
Tickers
AQST
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.